HIV/AIDS among African Americans: Progress or progression?

AIDS

Volumn 14, Issue 9, 2000, Pages 1237-1248

  Smith, Dawn K ^a   Gwinn, Marta ^a   Selik, Richard M ^a   Miller, Kim S ^a   Dean Gaitor, Hazel ^a   Imani Ma'at, P ^b   De Cock, Kevin M ^a   Gayle, Helene D ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Mailstop E 45 ^*  (United States)

Author keywords

African Americans; AIDS; Drug users; Epidemiology; HIV; Mortality; Seroprevalence; Sexual behavior

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; ETHNIC GROUP; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; MORTALITY; NEGRO; POVERTY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOCIAL CLASS; UNITED STATES; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK-TAKING; UNITED STATES;

EID: 0033948387     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200006160-00022     Document Type: Article

References (92)

1. 1. Centers for Disease Control. Update on Kaposi's sarcoma and opportunistic infections in previously healthy persons-U.S. MMWR 1982, 31:294-301.
2. 2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1998, 10 (2):1-43.
3. 3. Centers for Disease Control and Prevention. Diagnosis and reporting of HIV and AIDS in states with integrated HIV and AIDS surveillance - United States, January 1994-June 1997. MMWR 1998, 47 (15):309-314.
4. 4. Cowan DN, Brundage JF, Pomerantz RS. The incidence of HIV infection among men in the United States Army Reserve components, 1985-1991. AIDS 1994, 8:505-511.
5. 5. Cowan DN, Brundage JF, Pomerantz RS. HIV infection among women in the Army Reserve components. J Acquir Immune Defic Syndr 1994, 7:171-176.
6. 6. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and clinical and prevention purposes. JAMA 1998, 280:42-48.
7. 7. Busch MP, Aberle-Grasse J, Rawal BD, et al. Demographic correlates of HIV incidence among US blood donors. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, January-February 1999 [abstract 272].
8. 8. McQuillan GM, Khare, Karon JM et al. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:355-360.
9. 9. Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1995, 270:1372-1375.
10. 10. Janssen RS, St. Louis ME, Satten GA, et al. HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The HIV Surveillance Group. N Engl J Med 1992, 327:486-488.
11. 11. Mundy LM, Gopalan R, Quinn TC. More on routine HIV screening [letter]. N Engl J Med 1993, 328:1715-1716.
12. 12. US Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Baltimore: Williams & Wilkins; 1989:59, 132.
13. 13. Valleroy LA, MacKellar DA, Karon JM, et al. HIV infection in disadvantaged out-of-school youth: prevalence for U.S. Job Corps entrants, 1990-1996. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19:67-73.
14. 14. Valleroy LA, MacKellar DA, Rosen D, et al. HIV prevalence and predictors of unprotected receptive anal intercourse for 15-22-year-old men who have sex with men sampled in seven urban areas, USA. XII International Conference on AIDS. Geneva, June-July 1998 [abstract 23120].
15. 15. Centers for Disease Control. Update. trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR 1997, 46:165-173.
16. 16. United States Bureau of the Census. Resident Population of the United States. http://www.census.gov.
17. 17. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Supplemental Report 1999, 5 (1):1-13.
18. 18. Centers for Disease Control and Prevention. HIV & AIDS Trends. CDC Progress in Prevention Reports. Atlanta: CDC; 1996.
19. 19. Centers for Disease Control. HIV/AIDS Surveillance Report. 1993, 5 (4):1-33.
20. 20. Centers for Disease Control. HIV/AIDS Surveillance Report. 1994, 6 (2):1-39.
21. 21. Centers for Disease Control. HIV/AIDS Surveillance Report. 1995, 7 (2):1-38.
22. 22. Centers for Disease Control and Prevention. Update: trends in AIDS incidence - United States, 1996. MMWR 1997, 46: 861-867.
23. 23. Klevens RM, Fleming PL, Neal JJ, Li J. Does misclassification of HIV exposure impact AIDS trends among heterosexuals in the United States? XI International Conference on AIDS. Vancouver, July 1996 [abstract Th.C.340].
24. 24. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1997, 9 (2):1-43.
25. 25. Chan IS, Neaton JD, Saravolatz LD, et al. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. AIDS 1995, 9:1145-1151.
26. 26. Biggar RJ, Rosenberg PS, Cote T. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS/Cancer Match Study Group. Int J Cancer 1996, 68: 764-768. [Erratum published in Int J Cancer 1997; 70:727].
27. 27. Johnson CC, Wilcosky T, Kvale P, et al. Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Infection Study Group. Am J Epidemiol 1997, 146:470-475.
28. 28. Winston JA, Klotman PE. Are we missing an epidemic of HIV-associated nephropathy? J Am Soc Nephrol 1996, 7:1-7.
29. 29. Torok RJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United States - analysis of national mortality data, 1968-1991. Am J Hematol 1995, 50:84-90.
30. 30. Sullivan PS, Hanson DL, Chu SY, et al. Surveillance for thrombocytopenia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:374-379.
31. 31. Hu DJ, Fleming PL, Castro KG, et al. How important is race/ ethnicity as an indicator of risk for specific AIDS-defining conditions? J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10:374-380.
32. 32. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1999, 11 (11): 1-42.
33. 33. Kramarow E, Lentzner H, Rooks R, et al. Health, United States, 1999 with Health and Aging Chartbook. Hyattsville, MD:National Center for Health Statistics, 1999.
34. 34. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonorrhea urethritis and CD4 cell depletion. J Infect Dis 1995, 172:1469-1474.
35. 35. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997, 11:F85-F93.
36. 36. Critchlow CW, Kiviat NB. Detection of human immunodeficiency virus type 1 and type 2 in the female genital tract: implications for the understanding of virus transmission. Obstet Gynecol Surv 1997, 52:315-324.
37. 37. Ericksen KP, Trocki KF. Sex, alcohol and sexually transmitted diseases: a national survey. Fam Plan Perspect 1994, 26: 257-263.
38. 38. CDC. Summary of notifiable diseases, United States, 1996. MMWR 1997, 45 (53):1-103.
39. 39. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997, 337:105-111.
40. 40. Mayaud P, Mosha F, Todd J, et al. Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. AIDS 1997, 11:1873-1880.
41. 41. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 1995, 246:530-536.
42. 42. Wawer MJ, Gray RH, Sewankambo D, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998, 12: 1211-1225.
43. 43. St. Louis ME, Wasserheit JN, Gayle HD. Janus considers the HIV pandemic-harnessing recent advances to enhance HIV prevention [editorial]. Am J Public Health 1997, 87:10-12.
44. 44. Vernazza PL, Gilliam BL, Dyer, J et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997, 11:987-993.
45. 45. Nicolosi A. Zidovudine treatment and virus excretion in the cervicovaginal secretions of HIV-infected women. J Acquir Immune Defic Syndr 1993, 6:852-854.
46. 46. Mostad SB, Kreiss JK. Shedding of HIV-1 in the genital tract. AIDS 1996, 10:1305-1315.
47. 47. Markson L, Cunningham W, Anderson R, et al. Who receives highly active antiretroviral therapy (HAART)? Data from a Nationally Representative Sample. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, January-February 1999 [abstract 105].
48. 48. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States. JAMA 1999, 281:2305-2315.
49. 49. Bozzette S. Care for HIV in the US: access, quality, cost, and consequences. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, January-February, 1999 [session 33]. Available at: http://www.retroconference.org./99/hearlec. htm http://www.retrocon ference.org./
50. 50. Bellamy R. Genetic susceptibility to tuberculosis in human populations. Thorax 1998, 53:588-593.
51. 51. McNicholl JM, Smith DK, Quari SH, Hodge T. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele (Δ32 CCR5). Emerg Infect Dis 1997, 3:261-271.
52. 52. Kirschner DE, Sullivan AD. Modeling the influence of host genetic factors in HIV epidemics. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, January-February 1999 [session 152]. Available at: http://www.retroconference. org./99/http://www.retroconference.org./
53. 53. Tanfer K. National survey of men: design and execution. Fam Plann Perspect 1993, 25:83-86.
54. 54. Billy JOG, Tanfer K, Grady WR, Klepinger DH. The sexual behavior of men in the United States. Fam Plann Perspect 1993, 25:52-60.
55. 55. Ku L, Sonenstein FL, Lindberg LD, et al. Understanding changes in sexual activity among young metropolitan men:1979-1995. Fam Plann Perspect 1998, 30:256-262.
56. 56. Friedman SR, Young PA, Synder FR, et al. Racial differences in sexual behaviors related to AIDS in a nineteen-city sample of street-recruited drug injectors. AIDS Educ Prev 1993, 5: 196-211.
57. 57. Grinstead OA, Peterson JL, Faigeles B, Catania JA. Antibody testing and condom use among heterosexual African Americans at risk for HIV infection: the National AIDS Behavioral Surveys. Am J Public Health 1997, 87:857-859.
58. 58. Substance Abuse and Mental Health Services Administration. National household survey on drug abuse: population estimates 1997. Available at: http://www.samhsa.gov/oas/nhsda/pe1997/ popes105.htm.
59. 59. National Institute on Drug Abuse. National Household Survey on Drug Abuse: Population Estimates 1991. Rockville: US Department of Health and Human Services; 1991.
60. 60. Schoenborn CA, Marsh SL, Hardy AM. AIDS knowledge and attitudes for 1992. Data from the National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics. Adv Data 1994, 243:1-16.
61. 61. Klepinger DH, Milly JOG, Tanfer K, Grady WR. Perceptions of AIDS risk and severity and their association with risk-related behavior among U.S. men. Fam Plann Perspect 1993, 25:74-82.
62. 62. Berrios DC, Hearst N, Coates TJ, et al. HIV antibody testing among those at risk for infection: the National AIDS Behavioral Surveys. JAMA 1993, 270:1576-1580.
63. 63. Leigh BC, Temple MT, Trocki KF. The sexual behavior of US adults: results from a national survey. Am J Public Health 1993, 83:1400-1408.
64. 64. Marin B. Analysis of AIDS prevention among African Americans and Latinos in the United States. 1995. Report prepared for the Office of Technology Assessment, US Congress.
65. 65. Stanton BF, Li X, Ricardo I, et al. A randomized, controlled effectiveness trial of an AIDS prevention program for low-income African American youths. Arch Pediatr Adolesc Med 1996, 150:363-372.
66. 66. Jemmott JB, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial. JAMA 1998, 279:1529-1536.
67. 67. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk reduction intervention for young African American women. JAMA 1995, 274:1271-1276. [Response to letters: JAMA 1996, 275:594-595].
68. 67. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk reduction intervention for young African American women. JAMA 1995, 274:1271-1276. [Response to letters: JAMA 1996, 275:594-595].
69. 68. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. Science 1998, 280:1889-1894.
70. 69. Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. JAMA 1998, 280:1161-1167.
71. 70. Malow RM, West JA, Corrigan SA, et al. Outcome of psychoeducation for HIV risk reduction. AIDS Educ Prev 1994, 6:113-125.
72. 71. Cottler LB, Compton WM, Abdallah AB, et al. Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public Health Reports 1998, 113 (Suppl 1):31-41.
73. 72. Levy JA, Fox SE. The outreach-assisted model of partner notification with IDUs. Public Health Reports 1998, 113 (suppl 1): 160-169.
74. 73. Latkin CA, Mandell W, Vlahov D, et al. The long-term outcome of a personal network-oriented HIV prevention for injection drug users: the SAFE Study. Am J Community Psychol 1996, 24:341-364.
75. 74. Peterson JL, Coates TJ, Catania J, et al. Evaluation of an HIV risk reduction intervention among African American homosexual and bisexual men. AIDS 1996, 10:319-325.
76. 75. Winett RA, Kalichman SC. HIV sexual risk-reduction interventions for African American women [letter]. JAMA 1996, 275:593.
77. 76. Branson BM, Moore JS, Byers R. HIV sexual risk-reduction interventions for African American women [letter]. JAMA 1996, 275:593-594.
78. 77. Simon PA, Hu DJ, Diaz T, Kerndt PR. Income and AIDS rates in Los Angeles County. AIDS 1995, 9:281-284.
79. 78. Hu DJ, Frey R, Costa SJ, et al. Geographical AIDS rates and sociodemographic variables in the Newark, New Jersey metropolitan area. AIDS Public Policy J 1994, 9:20-25.
80. 79. Bonczar TP and Beck AJ. Lifetime likelihood of going to state or federal prison. Bureau of Justice Statistics Special Report, NCJ-160092. Washington, DC: United States Department of Justice; 1997.
81. 80. Horsburgh CR, Jarvis JQ, McArthur, et al. Seroconversion to human immunodeficiency virus in prison inmates. Am J Public Health 1990, 80:209-210.
82. 81. Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a statewide prison system. AIDS 1988, 2:363-367.
83. 82. Vlahov D. HIV-1 infection in the correctional setting [review]. NIDA Res Monogr 1992, 118:51-61.
84. 83. Hammett TM, Harmon P, Maruschak L. 1996-97 Update: HIV/AIDS, STDs and TB in Correctional Facilities. Issues and Practices in Criminal Justice; NCJ 176344. Washington DC: United St ates Department of Justice, Office of Justice Programs; 1999.
85. 84. Aral SO, Holmes KK, Padian NS, Cates W. Overview: individual and population approaches to the epidemiology and prevention of sexually transmitted diseases and human immunodeficiency virus infection. J Infect Dis 1996, 174 (suppl 2):S127-S133
86. 85. Rothenberg RB. Personal risk taking and the spread of disease: beyond core groups. J Infect Dis 1996, 174 (suppl 2):S144-S149.
87. 86. Shiboski S, Padian N. Population- and individual-based approaches to the design and analysis of epidemiologic studies of sexually transmitted disease transmission. J Infect Dis 1996, 174 (suppl2):S188-S200.
88. 87. Friedman SR, Neaigus A, Jose B, et al. Sociometric risk networks and risk for HIV infection. Am J Public Health 1997, 87: 1289-1296.
89. 88. Rothenberg SR, Sterk C, Toomey KE, et al. Using social network and ethnographic tools to evaluate syphilis transmission. Sex Trans Dis 1998, 25:154-160.
90. 89. Longshore D, Stein JA, Anglin MD. Ethnic differences in the psychosocial antecedents of needle/syringe disinfection. Drug Alcohol Depend 1996, 42:183-196.
91. 90. Latkin CA, Mandell W, Vlahov D. The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug Alcohol Depend 1996, 42: 175-181.
92. 91. Dalton HL. AIDS in blackface. Daedulus 1989, 118:205-227.